Mayo Clinic Proceedings Home

Palliative Medicine Consultation for Preparedness Planning in Patients Receiving Left Ventricular Assist Devices as Destination Therapy


      To assess the benefit of proactive palliative medicine consultation for delineation of goals of care and quality-of-life preferences before implantation of left ventricular assist devices as destination therapy (DT).


      We retrospectively reviewed the cases of patients who received DT between January 15, 2009, and January 1, 2010.


      Of 19 patients identified, 13 (68%) received proactive palliative medicine consultation. Median time of palliative medicine consultation was 1 day before DT implantation (range, 5 days before to 16 days after). Thirteen patients (68%) completed advance directives. The DT implantation team and families reported that preimplantation discussions and goals of care planning made postoperative care more clear and that adverse events were handled more effectively. Currently, palliative medicine involvement in patients receiving DT is viewed as routine by cardiac care specialists.


      Proactive palliative medicine consultation for patients being considered for or being treated with DT improves advance care planning and thus contributes to better overall care of these patients. Our experience highlights focused advance care planning, thorough exploration of goals of care, and expert symptom management and end-of-life care when appropriate.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lietz K
        • Long JW
        • Kfoury AG
        • et al.
        Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
        Circulation. 2007; 116: 497-505
        • Long JW
        • Healy AH
        • Rasmusson BY
        • et al.
        Improving outcomes with long-term “destination” therapy using left ventricular assist devices.
        J Thorac Cardiovasc Surg. 2008; 135: 1353-1360
        • Park SJ
        • Tector A
        • Piccioni W
        • et al.
        Left ventricular assist devices as destination therapy: a new look at survival.
        J Thorac Cardiovasc Surg. 2005; 129: 9-17
        • Rose EA
        • Gelijns AC
        • Moskowitz AJ
        • et al.
        Long-term use of a left ventricular assist device for end-stage heart failure.
        N Engl J Med. 2001; 345: 1435-1443
        • Slaughter MS
        • Rogers JG
        • Milano CA
        • et al.
        Advanced heart failure treated with continuous-flow left ventricular assist device.
        N Engl J Med. 2009; 361: 2241-2251
        • Boilson BA
        • Schirger JA
        • Durham III, JA
        • et al.
        Transformation of LVAD destination therapy, “good to great”: ever increasing survival benefit [abstract 3662].
        Circulation. 2009; 120: S844
        • MacIver J
        • Ross HJ
        Withdrawal of ventricular assist device support.
        J Palliat Care. 2005; 21: 151-156
        • Rizzieri AG
        • Verheijde JL
        • Rady MY
        • McGregor JL
        Ethical challenges with the left ventricular assist device as a destination therapy.
        Philos Ethics Humanit Med. 2008; 3: 20
        • Bieniarz MC
        • Delgado R
        The financial burden of destination left ventricular assist device therapy: who and when?.
        Curr Cardiol Rep. 2007; 9: 194-199
        • Zambroski CH
        Managing beyond an uncertain illness trajectory: palliative care in advanced heart failure.
        Int J Palliat Nurs. 2006; 12: 566-573
        • Zambroski CH
        • Combs P
        • Cronin SN
        • Pfeffer C
        • Edgar Allan Poe
        “the pit and the pendulum,” and ventricular assist devices.
        Crit Care Nurse. 2009; 29: 29-39
        • Casida JM
        • Peters RM
        • Magnan MA
        Self-care demands of persons living with an implantable left-ventricular assist device.
        Res Theory Nurs Pract. 2009; 23: 279-293
        • MacIver J
        • Ross HJ
        • Delgado DH
        • et al.
        Community support of patients with a left ventricular assist device: the Toronto General Hospital experience.
        Can J Cardiol. 2009; 25: e377-e381
        • Wilson SR
        • Givertz MM
        • Stewart GC
        • Mudge Jr, GH
        Ventricular assist devices the challenges of outpatient management.
        J Am Coll Cardiol. 2009; 54: 1647-1659
        • Dudzinski DM
        Ethics guidelines for destination therapy.
        Ann Thorac Surg. 2006; 81: 1185-1188
        • Swetz KM
        • Mueller PS
        • Ottenberg AL
        • Dib C
        • Freeman MR
        • Sulmasy DP
        The use of advance directives among patients with left ventricular assist devices.
        Hosp Pract (Minneap). 2011; 39: 78-84
        • Landzaat LH
        • Sinclair CT
        • Rosielle DA
        Continuous-flow left ventricular assist device [letter].
        N Engl J Med. 2010; 362: 1149
        • Bramstedt KA
        Destination nowhere: a potential dilemma with ventricular assist devices.
        ASAIO J. 2008; 54: 1-2
        • Bramstedt KA
        Elective inactivation of total artificial heart technology in non-futile situations: inpatients, outpatients and research participants.
        Death Stud. 2004; 28: 423-433
        • Bramstedt KA
        • Wenger NS
        When withdrawal of life-sustaining care does more than allow death to take its course: the dilemma of left ventricular assist devices.
        J Heart Lung Transplant. 2001; 20: 544-548
        • Mueller PS
        • Swetz KM
        • Freeman MR
        • et al.
        Ethical analysis of withdrawing ventricular assist device support.
        Mayo Clin Proc. 2010; 85: 791-797
        • Ferris H
        • Hunt S
        Destination ventricular assist devices for heart failure #205.
        J Palliat Med. 2009; 12: 956-957
      1. Schwarz ER, Philip KJ, Simsir SA, et al. Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sick [published online ahead of print February 27, 2010]. J Relig Health. Doi: 10.1007/s10943-010-9326-y.

        • Boyd KJ
        • Worth A
        • Kendall M
        • et al.
        Making sure services deliver for people with advanced heart failure: a longitudinal qualitative study of patients, family carers, and health professionals.
        Palliat Med. 2009; 23: 767-776
        • Goodlin SJ
        Palliative care in congestive heart failure.
        J Am Coll Cardiol. 2009; 54: 386-396
        • Jaarsma T
        • Beattie JM
        • Ryder M
        • et al.
        Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology.
        Eur J Heart Fail. 2009; 11: 433-443
        • O'Leary N
        • Murphy NF
        • O'Loughlin C
        • Tiernan E
        • McDonald K
        A comparative study of the palliative care needs of heart failure and cancer patients.
        Eur J Heart Fail. 2009; 11: 406-412
        • Pantilat SZ
        • Steimle AE
        Palliative care for patients with heart failure.
        JAMA. 2004; 291: 2476-2482
        • Widera E
        • Pantilat S
        Hospitalization as an opportunity to integrate palliative care in heart failure management.
        Curr Opin Support Palliat Care. 2009; 3: 247-251
        • Temel JS
        • Greer JA
        • Muzikansky A
        • et al.
        Early palliative care for patients with metastatic non-small-cell lung cancer.
        N Engl J Med. 2010; 363: 733-742